◀ Back to MAPK12
MAP3K13 — MAPK12
Text-mined interactions from Literome
Handley et al., Int Immunol 2007
(MAP Kinase Signaling System) :
Inhibition of
MLK activity using a pharmacological inhibitor, CEP11004,
blocks p38 and Jun N-terminal kinase (JNK)
MAPK activation in response to LPS and poly ( I:C ), but not zymosan
Korchnak et al., Cell Signal 2009
:
Mixed lineage kinase 3 (MLK3) is a mitogen activated protein kinase kinase kinase (
MAP3K ) that
activates multiple mitogen activated protein kinase (
MAPK ) pathways in response to growth factors, stresses and the pro-inflammatory cytokine, tumor necrosis factor (TNF)